ÇEKİÇ, Ş. Et Al. 2018. Omalizumab treatment in childhood chronic urticaria. Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , (Munich, Germany), 227.

ÇEKİÇ, Ş., Karali, Y., Canitez, Y., & Sapan, N., (2018). Omalizumab treatment in childhood chronic urticaria . Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) (pp.227). Munich, Germany

ÇEKİÇ, ŞÜKRÜ Et Al. "Omalizumab treatment in childhood chronic urticaria," Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Munich, Germany, 2018

ÇEKİÇ, ŞÜKRÜ Et Al. "Omalizumab treatment in childhood chronic urticaria." Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , Munich, Germany, pp.227, 2018

ÇEKİÇ, Ş. Et Al. (2018) . "Omalizumab treatment in childhood chronic urticaria." Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , Munich, Germany, p.227.

@conferencepaper{conferencepaper, author={ŞÜKRÜ ÇEKİÇ Et Al. }, title={Omalizumab treatment in childhood chronic urticaria}, congress name={Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI)}, city={Munich}, country={Germany}, year={2018}, pages={227} }